Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
cancer
4
×
life sciences
national blog main
pfizer
4
×
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
celgene
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
agenus
boehringer ingelheim
clinical trials
deals
fda
genentech
investing
johnson & johnson
What
bio
companies
4
×
roundup
approved
drug
merck
pharmaceutical
alzheimer’s
arena’s
bounty
cancer
cig
combo
comeback
corner
dating
deals
delivered
different
digital
disease
epidemic
expressing
fail
fatty
fda
frenzied
game
gene
growing
happening
immunotherapies
increases
ipo
kgaa
known
latest
led
life
little
Language
Current search:
biotech
×
companies
×
pfizer
×
cancer
×
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More